Related references
Note: Only part of the references are listed.Linear regression analysis of silychristin A, silybin A and silybin B contents in Silybum marianum
Sameh F. AbouZid et al.
NATURAL PRODUCT RESEARCH (2020)
Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases
Ludovico Abenavoli et al.
PHYTOTHERAPY RESEARCH (2018)
Diallyl Polysulfides from Allium sativum as Immunomodulators, Hepatoprotectors, and Antimycobacterial Agents
Carel Oosthuizen et al.
JOURNAL OF MEDICINAL FOOD (2017)
Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance
Anika Mann et al.
HUMAN CELL (2017)
Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism
Raghu Ramanathan et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Effect of Prophylactic Use of Silymarin on Anti-tuberculosis Drugs Induced Hepatotoxicity
Eunyoung Heo et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2017)
Clinical and experimental research in antituberculosis drug-induced hepatotoxicity: a review
Udhaya Lavinya Baskaran et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2017)
Early monitoring for detection of antituberculous drug-induced hepatotoxicity
Chang Min Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2016)
Mechanism of isoniazid-induced hepatotoxicity: then and now
Imir Metushi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
Simin Zhang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Reparation of Isoniazid and Rifampicin Combinatorial Therapy-Induced Hepatotoxic Effects by Bacopa monnieri
Sabina Evan Prince et al.
PHARMACOLOGY (2016)
Amelioration of anti-tuberculosis drug induced oxidative stress in kidneys by Spirulina fusiformis in a rat model
Sherry Joseph Martin et al.
RENAL FAILURE (2016)
Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients
Shanshan Wu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Treatment of Tuberculosis
C. Robert Horsburgh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
Xiang Wan et al.
BMC MEDICAL RESEARCH METHODOLOGY (2014)
Mild Isoniazid-Induced Liver Injury in Humans Is Associated with an Increase in Th17 Cells and T Cells Producing IL-10
Imir G. Metushi et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Potential protection of vitamin C against liver-lesioned mice
Min Su et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Attenuation of anti-tuberculosis therapy induced hepatotoxicity by Spirulina fusiformis, a candidate food supplement
Sherry Joseph Martin et al.
TOXICOLOGY MECHANISMS AND METHODS (2014)
A PROSPECTIVE STUDY FOR EVALUATING THE EFFECT OF SILYMARIN ON HEPATIC FUNCTIONS IN TUBERCULAR PATIENTS RECEIVING DOTS
Sharad Bedi et al.
CHEST (2013)
Hepatoprotective effects of S-adenosylmethionine and silybin on canine hepatocytes in vitro
A. Y. Au et al.
JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION (2013)
Milk Thistle and Its Derivative Compounds: A Review of Opportunities for Treatment of Liver Disease
E. S. Hackett et al.
JOURNAL OF VETERINARY INTERNAL MEDICINE (2013)
Hepatotoxicity Related to Anti-tuberculosis Drugs: Mechanisms and Management
Vidyasagar Ramappa et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2013)
Antioxidant, anti-inflammatory and hepatoprotective effects of silymarin on hepatic dysfunction induced by sodium nitrite
Imam O. Sherif et al.
EUROPEAN CYTOKINE NETWORK (2013)
Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model
M. Singh et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2012)
A Fresh Look at the Mechanism of Isoniazid-Induced Hepatotoxicity
I. G. Metushi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias
Karsten Knobloch et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2011)
Milk Thistle in Liver Diseases: Past, Present, Future
Ludovico Abenavoli et al.
PHYTOTHERAPY RESEARCH (2010)
Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic hepatitis C and murine acute hepatocyte disorder
Kazuhiro Kataoka et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2010)
Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies
Qin Liu et al.
BMC PUBLIC HEALTH (2008)
Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
Alma Tostmann et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Influence of Diabetes on Liver Injury Induced by Antitubercular Drugs and on Silymarin Hepatoprotection in Rats
R. K. Srivastava et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2008)
Effect of silibinin on the pharmacokinetics of pyrazinamide and pyrazinoic acid in rats
Jhy-Wen Wu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry
James I. Lee et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2007)
An official ATS statement: Hepatotoxicity of antituberculosis therapy
Jussi J. Saukkonen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Iron and iron chelating agents modulate Mycobacterium tuberculosis growth and monocyte-macrophage viability and effector functions
L Cronjé et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin
SA Tasduq et al.
HEPATOLOGY RESEARCH (2005)
Herb-drug interactions - A literature review
ZP Hu et al.
DRUGS (2005)
Share Paper
